Xponance’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Xponance's HALO Position: Q1 2026 in Review
Xponance increased its Halozyme (HALO) stake by 13% in Q1 2026, buying an estimated $217K and bringing the position to 26,039 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #609.
Xponance first reported a position in HALO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.86M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Xponance held 26,039 shares of Halozyme worth $1.68M as of Q1 2026.
- Xponance bought 3,074 Halozyme shares in Q1 2026, an estimated $217K.
- Halozyme made up 0.01% of Xponance's portfolio in Q1 2026, its #609 holding.
- Xponance first reported a position in Halozyme in Q4 2020 and has held it in 22 quarters since.
- Xponance's Halozyme position peaked at $1.86M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.